Kestrel Biologic

Kestrel Biologic is a regenerative medicine company specializing in the development and distribution of human birth tissue-based allografts. The company's flagship product line, Amnio-Maxx, utilizes amniotic membrane and fluid to provide a structural matrix for tissue repair and to reduce inflammation in various clinical settings. These products are primarily used in orthopedics, podiatry, and wound care to treat conditions such as chronic wounds, tendonitis, and joint injuries. Kestrel Biologic focuses on providing high-quality, minimally manipulated HCT/P (Human Cells, Tissues, and Cellular and Tissue-Based Products) that adhere to strict safety and quality standards. The company serves healthcare providers across the United States, offering biologic solutions designed to enhance the body's natural healing processes.